Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with st-segment elevation myocardial infarction

This publication has 25 references indexed in Scilit:

• Therapy-Dependent Influence of Time-to-Treatment Interval on Myocardial Salvage in Patients With Acute Myocardial Infarction Treated With Coronary Artery Stenting or Thrombolysis
  Circulation, 2003
• Thrombolysis in myocardial infarction myocardial perfusion grade in angiography correlates with myocardial salvage in patients with acute myocardial infarction treated with stenting or thrombolysis
  Journal of the American College of Cardiology, 2003
• Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14
  European Heart Journal, 2000
• Abciximab Facilitates the Rate and Extent of Thrombolysis
  Circulation, 1999
• TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial Infarction
  Circulation, 1998
• TNK-Tissue Plasminogen Activator in Acute Myocardial Infarction
  Circulation, 1997
• Time from symptom onset to treatment and outcomes after thrombolytic therapy
  Journal of the American College of Cardiology, 1996
• Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) 4 trial
  Journal of the American College of Cardiology, 1994
• Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
  Published by Elsevier ,1994
• Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
  Circulation, 1987